IM ketamine in dose finding and then continuation for phantom limb

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 11 Dec 2025: Trial registered, NCT07276542
  2. 15 Jan 2026: Trial started, NCT07276542

The trials

NCT07276542: Clinical Trial Exploring the Outpatient Treatment of Phantom Limb Pain With Ketamine Administration in a Six Month Study With a Minimum Remission Period of 7 Days Between Treatment Session. 25-30 Subjects With an Ongoing History of Significant PLP.--FDA and IRB Approved.

State
Under way
Phase
Phase 2 and Phase 3
People
30 planned
Started
15 Jan 2026
Primary completion
31 Dec 2026
Arms
PLP Ketamine Intervention
Results
None posted
  1. 11 Dec 2025: Trial registered
  2. 15 Jan 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.